CLOSURE develops adhesive for emphysema:
This article was originally published in Clinica
CLOSURE Medical is developing an adhesive product for the minimally invasive treatment of emphysema. The adhesive is to be used during an endobronchial lung volume reduction (LVR) procedure to achieve bronchial occlusion, which causes the dysfunctional lung tissue to collapse, making room for the expansion of healthier lung tissue. A feasibility study of the product in 10 goats showed that it achieved LVR in all the animals. The Raleigh, North Carolina company is to conduct another animal study to optimise the procedure before entering human trials.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.